SCHEMBL28546121

SCHEMBL28546121

C#Cc1cccc(Nc2ccnc(OCCN3CCN(C)CC3)n2)c1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AIMP2 Q13155 2/20 0.45
▸ EGFR P00533 7/20 0.41
▸ JAK2 O60674 2/20 0.41
▸ JAK3 P52333 2/20 0.41
▸ SRC P12931 5/20 0.41
▸ FGFR1 P11362 1/20 0.41
▸ GAK O14976 2/20 0.41
▸ KDR P35968 1/20 0.40
▸ PDGFRB P09619 1/20 0.39
▸ TDO2 P48775 2/20 0.39
▸ IDO1 P14902 1/20 0.38
▸ NTRK1 P04629 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ YES1 P07947 1/20 0.38
▸ ERBB2 P04626 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30213747 1.00 AIMP2 (0.45) AIMP2EGFRJAK2JAK3SRC
SCHEMBL30213714 0.89 EGFR (0.49) EGFRSRCGAK
SCHEMBL30213776 0.84 EGFR (0.55) EGFRSRCKDR
SCHEMBL28549641 0.81 EGFR (0.41) AIMP2EGFRJAK2JAK3GAK
SCHEMBL30213684 0.77 EGFR (0.54) AIMP2EGFRNTRK1ERBB2
SCHEMBL28540768 0.77 EGFR (0.54) AIMP2EGFRNTRK1ERBB2
SCHEMBL28537354 0.72 EGFR (0.63) EGFRERBB2
SCHEMBL28540776 0.72 EGFR (0.48) EGFRGAKKDRTDO2ERBB2
SCHEMBL30213605 0.71 EGFR (0.45) EGFRJAK2JAK3SRCFGFR1
SCHEMBL22338207 0.70 EGFR (0.80) EGFRJAK2JAK3SRCGAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112574177-A Pyrimidine derivatives and application thereof in preparing antitumor drugs 陕西师范大学 2021-03-30 — — CN claimed
CN-112574177-A Pyrimidine derivatives and application thereof in preparing antitumor drugs 陕西师范大学 2021-03-30 — — CN disclosed
Send feedback